Novick A C
Department of Urology, Cleveland Clinic Foundation, Ohio.
Eur J Vasc Surg. 1994 Jan;8(1):1-9. doi: 10.1016/s0950-821x(05)80111-2.
The management of patients with renal artery disease has changed in recent years. This has occurred due to the advent of PTA as an effective method of treatment for certain patients, an enhanced appreciation of advanced atherosclerotic renal artery disease as a correctable cause of renal failure, and improved results of surgical revascularisation in both older patients with severe aortic atherosclerosis and younger patients with branch renal artery disease. PTA currently yields excellent results and is the treatment of choice for patients with fibrous dysplasia of the main renal artery and non-ostial atherosclerotic lesions. Most reports in the literature indicate that surgical revascularisation provides more effective therapy for patients with ostial atherosclerotic lesions. Surgical revascularisation also remains the treatment of choice for the majority of patients with branch renal artery disease, a renal artery aneurysm, renal artery occlusion, and recurrent renal artery stenosis after failed PTA or surgery. Excellent clinical results can be achieved with both PTA and surgical revascularisation in properly selected patients.
近年来,肾动脉疾病患者的治疗方式发生了变化。这是由于经皮腔内血管成形术(PTA)的出现,它成为某些患者有效的治疗方法;对晚期动脉粥样硬化性肾动脉疾病作为肾衰竭可纠正病因的认识有所提高;以及在患有严重主动脉粥样硬化的老年患者和患有分支肾动脉疾病的年轻患者中,手术血管重建的效果得到改善。目前,PTA取得了优异的效果,是主肾动脉纤维发育异常和非开口处动脉粥样硬化病变患者的首选治疗方法。文献中的大多数报告表明,手术血管重建为开口处动脉粥样硬化病变患者提供了更有效的治疗。对于大多数患有分支肾动脉疾病、肾动脉瘤、肾动脉闭塞以及PTA或手术失败后复发性肾动脉狭窄的患者,手术血管重建仍然是首选治疗方法。在适当选择的患者中,PTA和手术血管重建都能取得出色的临床效果。